Budesonide 15 mg vs placebo
Clinical remission · Patients with active Crohn's disease
Budesonide 15 mg probably leads to higher induction of clinical remission (CDAI < 150) ‐ 8 weeks compared with placebo (moderate certainty).
1 finding from 1 review
- RR 2.25 [1.35, 3.76]2 studies · 181 participantsModerate